Company Name:CRISPR Therapeutics AG
CEO: Samarth Kulkarni

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: CH

Description: CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.


Key numbers

Market Capitalization:6001811160
Shares Outstanding: 70172000
Float: 53237321
Next Earning Date:2020-11-04
TTm EPS: 0.6138
TTm Dividend Rate:
200 days moving average:59.13
50 days moving average: 76.01
One day percent Change: -1.04



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,